|
| 37848643 | A Sustainable Translational Sheep Model for Planned Cesarean Delivery of Contraction-Free Ewes. | Reprod Sci | 2024 |
| 34127159 | The association between history of prenatal loss and maternal psychological state in a subsequent pregnancy: an ecological momentary assessment (EMA) study. | Psychol Med | 2023 |
| 37651851 | Alterations of materno-placento-fetal glucose homeostasis after a single course of antenatal betamethasone. | Placenta | 2023 |
| 37571998 | Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression. | Leuk Lymphoma | 2023 |
| 37811749 | Parity modulates impact of BMI and gestational weight gain on gut microbiota in human pregnancy. | Gut Microbes | 2023 |
| 37189770 | TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia. | Biomedicines | 2023 |
| 36724515 | Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML. | Blood Adv | 2023 |
| 36697862 | Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies. | Nature | 2023 |
| 36477975 | Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML. | Blood Adv | 2023 |
| 36689999 | European guidelines on perinatal care: corticosteroids for women at risk of preterm birth. | J Matern Fetal Neonatal Med | 2023 |
| 36607374 | Aortitis PET Imaging in VEXAS Syndrome: A Case Report. | Clin Nucl Med | 2023 |
| 36794507 | Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia <i>FLT3</i>-ITD patients. | Haematologica | 2023 |
| 34757455 | Response to Letter to the editor on: "Never too late? Quadruplets at the age of 65Â years". | Arch Gynecol Obstet | 2022 |
| 35546498 | Optimized RNA isolation of FFPE uterine scar tissues for RNA expression analyses delineated by laser microdissection. | Biotechniques | 2022 |
| 35611816 | Does the use of chitosan covered gauze for postpartum hemorrhage reduce the need for surgical therapy including hysterectomy? A databased historical cohort study. | J Perinat Med | 2022 |
| 35474100 | Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia. | Leukemia | 2022 |
| 35438802 | A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations. | Br J Haematol | 2022 |
| 35750691 | A multiparametric niche-like drug screening platform in acute myeloid leukemia. | Blood Cancer J | 2022 |
| 36520473 | An unexpected partnership targeting FLT3wt AML. | Blood | 2022 |
| 36431240 | Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL). | J Clin Med | 2022 |
| 36606049 | Does <sup>18</sup>F-FDG PET/CT add value to conventional imaging in clinical assessment of chronic disseminated candidiasis? | Front Med (Lausanne) | 2022 |
| 36570694 | Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively. | Hemasphere | 2022 |
| 36181735 | Placenta Accreta Spectrum Part II: hemostatic considerations based on an extended review of the literature. | J Perinat Med | 2022 |
| 36181730 | Placenta Accreta Spectrum Part I: anesthesia considerations based on an extended review of the literature. | J Perinat Med | 2022 |
| 36394552 | Intraoperative ultrasound during repeat cesarean delivery facilitates sampling of uterine scar tissue. | J Perinat Med | 2022 |
| 33544204 | Reply to: "Hysterectomy versus continuing conservative management: which is better for disseminated intravascular coagulation?"; Shinya Matsuzaki, MD, PhD, Yoshikazu Nagase, MD, Masayuki Endo, MD, PhD, Tadashi Kimura, MD, PhD. | Arch Gynecol Obstet | 2022 |
| 35284959 | Risk factors and outcomes associated with type of uterine rupture. | Arch Gynecol Obstet | 2022 |
| 35113241 | Reliability of a novel approach for reference-based cell type estimation in human placental DNA methylation studies. | Cell Mol Life Sci | 2022 |
| 34895843 | Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group. | Clin Lymphoma Myeloma Leuk | 2022 |
| 34766259 | Placenta Percreta Presents with Neoangiogenesis of Arteries with Von Willebrand Factor-Negative Endothelium. | Reprod Sci | 2022 |
| 33043739 | Effects of azacitidine in 93 patients with <i>IDH1/2</i> mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study. | Leuk Lymphoma | 2021 |
| 33881523 | Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study. | Blood | 2021 |
| 33713033 | Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study. | Acta Obstet Gynecol Scand | 2021 |
| 33811336 | Developing a database for multicenter evaluation of placenta accreta spectrum. | Acta Obstet Gynecol Scand | 2021 |
| 33811335 | The relation between maternal obesity and placenta accreta spectrum: A multinational database study. | Acta Obstet Gynecol Scand | 2021 |
| 33811334 | When a rare condition creates a scientific society: The history of the International Society for Placenta Accreta Spectrum (IS-PAS). | Acta Obstet Gynecol Scand | 2021 |
| 33811333 | Performance of antenatal imaging to predict placenta accreta spectrum degree of severity. | Acta Obstet Gynecol Scand | 2021 |
| 33690800 | Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML. | Blood | 2021 |
| 33631961 | Feasibility of Umbilical Cord Blood Collection in Neonates at Risk of Brain Damage-A Step Toward Autologous Cell Therapy for a High-risk Population. | Cell Transplant | 2021 |
| 33524163 | Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study. | Acta Obstet Gynecol Scand | 2021 |
| 34944023 | The Methyltransferase Smyd1 Mediates LPS-Triggered Up-Regulation of IL-6 in Endothelial Cells. | Cells | 2021 |
| 34822779 | Over-celling fetal microbial exposure. | Cell | 2021 |
| 34410352 | Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy. | Blood | 2021 |
| 34495287 | UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome. | JAMA Dermatol | 2021 |
| 34446099 | Betamethasone administration during pregnancy is associated with placental epigenetic changes with implications for inflammation. | Clin Epigenetics | 2021 |
| 34252994 | Dosage escalation of antenatal steroids in preterm twin pregnancies does not improve long-term outcome. | J Perinat Med | 2021 |
| 34206212 | Detection of Microplastic in Human Placenta and Meconium in a Clinical Setting. | Pharmaceutics | 2021 |
| 34146145 | Never too late? Quadruplets at the age of 65Â years. | Arch Gynecol Obstet | 2021 |
| 34229368 | Online survey on uterotomy closure techniques in caesarean section. | J Perinat Med | 2021 |
| 33972766 | Fetal meconium does not have a detectable microbiota before birth. | Nat Microbiol | 2021 |